212 related articles for article (PubMed ID: 24023643)
21. Human endogenous retrovirus K (HERV-K) is expressed in villous and extravillous cytotrophoblast cells of the human placenta.
Kämmerer U; Germeyer A; Stengel S; Kapp M; Denner J
J Reprod Immunol; 2011 Sep; 91(1-2):1-8. PubMed ID: 21840605
[TBL] [Abstract][Full Text] [Related]
22. Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques.
Iyer SS; Gangadhara S; Victor B; Shen X; Chen X; Nabi R; Kasturi SP; Sabula MJ; Labranche CC; Reddy PB; Tomaras GD; Montefiori DC; Moss B; Spearman P; Pulendran B; Kozlowski PA; Amara RR
J Virol; 2016 Oct; 90(19):8842-54. PubMed ID: 27466414
[TBL] [Abstract][Full Text] [Related]
23. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
24. The human endogenous retrovirus K(HML-2) has a broad envelope-mediated cellular tropism and is prone to inhibition at a post-entry, pre-integration step.
Kramer P; Lausch V; Volkwein A; Hanke K; Hohn O; Bannert N
Virology; 2016 Jan; 487():121-8. PubMed ID: 26517399
[TBL] [Abstract][Full Text] [Related]
25. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus.
van Diepen MT; Chapman R; Douglass N; Galant S; Moore PL; Margolin E; Ximba P; Morris L; Rybicki EP; Williamson AL
J Virol; 2019 Apr; 93(8):. PubMed ID: 30760570
[TBL] [Abstract][Full Text] [Related]
26. The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expression.
Morozov VA; Dao Thi VL; Denner J
PLoS One; 2013; 8(8):e70399. PubMed ID: 23950929
[TBL] [Abstract][Full Text] [Related]
27. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.
Wang-Johanning F; Radvanyi L; Rycaj K; Plummer JB; Yan P; Sastry KJ; Piyathilake CJ; Hunt KK; Johanning GL
Cancer Res; 2008 Jul; 68(14):5869-77. PubMed ID: 18632641
[TBL] [Abstract][Full Text] [Related]
28. Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope.
An DS; Xie Ym ; Chen IS
J Virol; 2001 Apr; 75(7):3488-9. PubMed ID: 11238877
[TBL] [Abstract][Full Text] [Related]
29. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
[TBL] [Abstract][Full Text] [Related]
30. Protection against melanoma by vaccination with Bacille Calmette-Guerin (BCG) and/or vaccinia: an epidemiology-based hypothesis on the nature of a melanoma risk factor and its immunological control.
Krone B; Kölmel KF; Henz BM; Grange JM
Eur J Cancer; 2005 Jan; 41(1):104-17. PubMed ID: 15617995
[TBL] [Abstract][Full Text] [Related]
31. A Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia Virus MVA Activates Specific CD8 and CD4 T Cells in Mice.
Kalodimou G; Veit S; Jany S; Kalinke U; Broder CC; Sutter G; Volz A
Viruses; 2019 Dec; 12(1):. PubMed ID: 31878180
[TBL] [Abstract][Full Text] [Related]
32. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
[TBL] [Abstract][Full Text] [Related]
33. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
[TBL] [Abstract][Full Text] [Related]
34. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
[TBL] [Abstract][Full Text] [Related]
35. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
[TBL] [Abstract][Full Text] [Related]
37. Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.
Tönjes RR; Limbach C; Löwer R; Kurth R
J Virol; 1997 Apr; 71(4):2747-56. PubMed ID: 9060628
[TBL] [Abstract][Full Text] [Related]
38. Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection.
Michaud HA; de Mulder M; SenGupta D; Deeks SG; Martin JN; Pilcher CD; Hecht FM; Sacha JB; Nixon DF
Retrovirology; 2014 Jan; 11():10. PubMed ID: 24472118
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIV.
Ourmanov I; Brown CR; Moss B; Carroll M; Wyatt L; Pletneva L; Goldstein S; Venzon D; Hirsch VM
J Virol; 2000 Mar; 74(6):2740-51. PubMed ID: 10684290
[TBL] [Abstract][Full Text] [Related]
40. Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model.
Carroll MW; Overwijk WW; Chamberlain RS; Rosenberg SA; Moss B; Restifo NP
Vaccine; 1997 Mar; 15(4):387-94. PubMed ID: 9141209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]